Mar 14, 2026GLP-1 Receptor Agonists for Obesity: Benefits and RisksGLP-1 drugs deliver unusually large weight loss and may improve cardiovascular outcomes, but GI effects, lean mass, surgery, and long-term use complicate choice.semaglutidetirzepatideglp-1 agonistsRead article →